Celltrion files Herceptin biosimilar SC formulation with EMA Korea Biomedical Review 09:03 Thu, 30 Apr
Ray Therapeutics Granted Priority Medicines (prime) Designation from the European Medicines Agency for RTx-015 in Retinitis Pigmentosa Business Wire (Press Release) 13:04 Wed, 29 Apr
Soligenix Announces Interim Results from the Phase 3 FLASH2 Trial Evaluating HyBryte™ in Treatment of Cutaneous T-Cell Lymphoma PR Newswire (Press Release) 12:30 Tue, 28 Apr
VectorY Therapeutics Receives U.K. Mhra Authorization and EMA Approval to Initiate Phase 1/2 pioneer-Als Clinical Trial of VTx-002 in People Living with Amyotrophic Lateral Sclerosis (Als) Business Wire (Press Release) 12:02 Tue, 28 Apr
EMA backs plozasiran for rare lipid disorder with high pancreatitis risk Pharmafile 11:08 Mon, 27 Apr
Novartis Regulatory Wins Raise Questions On Growth And Valuation Gap Simply Wall St 10:57 Sun, 26 Apr
Arrowhead Pharmaceuticals Receives Positive Chmp Opinion Recommending Approval of Redemplo® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS) in Europe Business Wire (Press Release) 11:40 Fri, 24 Apr